Analog Devices Inc: Form 10-Q for the period ended Jul 29, 2023
Filed with the SEC on Aug 23, 2023 and accepted by EDGAR at Aug 23, 2023, 07:05 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-07-29. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-04-30 to 2023-07-29 | $3.08bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2022-10-30 to 2023-07-29 | $9.59bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-04-30 to 2023-07-29 | $1.11bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2022-10-30 to 2023-07-29 | $3.36bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2023-04-30 to 2023-07-29 | $1.96bn | us-gaap:GrossProfit |
| Gross profit | 9 months2022-10-30 to 2023-07-29 | $6.23bn | us-gaap:GrossProfit |
| Research and development | 3 months2023-04-30 to 2023-07-29 | $423.8m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2022-10-30 to 2023-07-29 | $1.25bn | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2023-04-30 to 2023-07-29 | $334.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2022-10-30 to 2023-07-29 | $984.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-04-30 to 2023-07-29 | $929.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2022-10-30 to 2023-07-29 | $3.19bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-04-30 to 2023-07-29 | $69.3m | us-gaap:InterestExpense |
| Interest expense | 9 months2022-10-30 to 2023-07-29 | $193.1m | us-gaap:InterestExpense |
| Income tax | 3 months2023-04-30 to 2023-07-29 | −$2.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2022-10-30 to 2023-07-29 | $220.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-04-30 to 2023-07-29 | $877.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2022-10-30 to 2023-07-29 | $2.82bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-04-30 to 2023-07-29 | $1.74 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2022-10-30 to 2023-07-29 | $5.55 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-04-30 to 2023-07-29 | $1.75 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2022-10-30 to 2023-07-29 | $5.59 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-04-30 to 2023-07-29 | 503,503,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2022-10-30 to 2023-07-29 | 507,804,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2022-10-30 to 2023-07-29 | $3.63bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2022-10-30 to 2023-07-29 | $785.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2022-10-30 to 2023-07-29 | $1.25bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2022-10-30 to 2023-07-29 | $2.49bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-07-29 | $1.15bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-07-29 | $4.84bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-07-29 | $49.35bn | us-gaap:Assets |
| Current liabilities | At period end2023-07-29 | $2.83bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2023-07-29 | $6.52bn | us-gaap:LongTermDebt |
| Short-term borrowings | At period end2023-07-29 | $544.7m | us-gaap:CommercialPaper |
| Shareholders' equity | At period end2023-07-29 | $35.90bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2023-07-29 | 498,313,956 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000006281-23-000179. Last ingested by Listed: Oct 27, 2026, 17:29 ET. Listed shows no prices and gives no investment advice.